Syapse, a Palo ALto, CA-based developer of applications that enable the generation and use of omics profiles in diagnosing and treating patients, raised a Series A venture capital funding.
The round, whose amount was not disclosed, was led by The Social+Capital Partnership. In conjunction with the investment, Social Capital founder Chamath Palihapitiya joined Syapse’s Board of Directors.
Built on a cloud-based semantic data platform, Syapse applications enable the generation and use of omics profiles in diagnosing and treating patients at diagnostic companies, research institutions, medical centers, and payers. Syapse is compatible with all major sequencers, and is a launch partner of Illumina’s BaseSpace.
According to a written statement, the company’s software is now involved in the processing of over 3,000 patient genomes and thousands of transcriptome, proteome, immunome, and microbiome profiles per quarter.
The company, which was co-founded at Stanford University by Jonathan Hirsch, President, Tony Loeser, Chief Technology Officer, and Glenn Winokur, CEO, is currently hiring (read here).